Sarepta Therapeutics, Inc.·4

Mar 6, 8:00 PM ET

Mayo Stephen 4

4 · Sarepta Therapeutics, Inc. · Filed Mar 6, 2024

Insider Transaction Report

Form 4
Period: 2024-03-05
Mayo Stephen
Director
Transactions
  • Sale

    Common Stock

    2024-03-05$122.96/sh3,135$385,4806,621 total
Footnotes (1)
  • [F1]Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4